Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Lennox, Belinda R; Tomei, Giuliano; Vincent, Sally-Anne; Yeeles, Ksenija; Pollard, Rebecca; Palmer-Cooper, Emma; Jones, Peter; Zandi, Michael S; Coles, Alasdair

Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Accepted version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/283573

Repository DOI

https://doi.org/10.17863/CAM.30935

Files

Accepted version (69.5 KB)

Type

Article

Authors

Lennox, Belinda R

https://orcid.org/0000-0002-4972-8786

Tomei, Giuliano

Vincent, Sally-Anne

Yeeles, Ksenija

Pollard, Rebecca

Show 4 more

Keywords

NMDA, neuroimmunology, schizophrenia, Adolescent, Adult, Antibodies, Feasibility Studies, Female, Humans, Immunoglobulins, Intravenous, Immunologic Factors, Immunotherapy, Male, Potassium Channels, Voltage-Gated, Psychotic Disorders, Receptors, GABA-A, Receptors, N-Methyl-D-Aspartate, Young Adult

Journal Title

J Neurol Neurosurg Psychiatry

Journal ISSN

0022-3050
1468-330X

Volume Title

90

Publisher

BMJ

Publisher DOI

https://doi.org/10.1136/jnnp-2018-318124

Rights

http://www.rioxx.net/licenses/all-rights-reserved

Sponsorship

Stanley Medical Research Institute (SMRI) (14T-004)
Medical Research Council (MR/N019067/1)
Medical Research Council (MR/J012939/1)

Collections

Cambridge University Research Outputs